[go: up one dir, main page]

AU7378396A - Transduction of hematopoietic cells by viral vector and a cationic lipid - Google Patents

Transduction of hematopoietic cells by viral vector and a cationic lipid

Info

Publication number
AU7378396A
AU7378396A AU73783/96A AU7378396A AU7378396A AU 7378396 A AU7378396 A AU 7378396A AU 73783/96 A AU73783/96 A AU 73783/96A AU 7378396 A AU7378396 A AU 7378396A AU 7378396 A AU7378396 A AU 7378396A
Authority
AU
Australia
Prior art keywords
transduction
viral vector
cationic lipid
hematopoietic cells
hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73783/96A
Inventor
Pervin Anklesaria
Carmel M. Lynch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ampliphi Biosciences Corp
Original Assignee
Targeted Genetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Genetics Corp filed Critical Targeted Genetics Corp
Publication of AU7378396A publication Critical patent/AU7378396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU73783/96A 1995-09-28 1996-09-27 Transduction of hematopoietic cells by viral vector and a cationic lipid Abandoned AU7378396A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US447795P 1995-09-28 1995-09-28
US004477 1995-09-28
US57233195A 1995-12-14 1995-12-14
US572331 1995-12-14
US1566596P 1996-04-19 1996-04-19
US015665 1996-04-19
PCT/US1996/015580 WO1997012052A1 (en) 1995-09-28 1996-09-27 Transduction of hematopoietic cells by viral vector and a cationic lipid

Publications (1)

Publication Number Publication Date
AU7378396A true AU7378396A (en) 1997-04-17

Family

ID=27357640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73783/96A Abandoned AU7378396A (en) 1995-09-28 1996-09-27 Transduction of hematopoietic cells by viral vector and a cationic lipid

Country Status (2)

Country Link
AU (1) AU7378396A (en)
WO (1) WO1997012052A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264012C (en) 1996-08-13 2011-04-26 Chiron Corporation Compositions and methods for polynucleotide delivery
US6197332B1 (en) 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
US11793833B2 (en) 2016-12-02 2023-10-24 Juno Therapeutics, Inc. Engineered B cells and related compositions and methods
CN116024172B (en) * 2021-10-27 2025-06-03 复旦大学 Application of a cationic compound in preparing a hematopoietic stem cell or progenitor cell mobilization agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707091B1 (en) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Retroviral vector for gene transfer and expression in eukaryotic cells.
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells

Also Published As

Publication number Publication date
WO1997012052A1 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
AU5638496A (en) Viral vectors
AU1688695A (en) Adenoviral-mediated method of cell transfection
AU7331796A (en) Knapsack
AU5979296A (en) Peptide-enhanced cationic lipid transfections
AU6759596A (en) Compensation of dispersion
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU5315796A (en) Mammalian expression vectors
AU1930495A (en) Serum-free production of packaged viral vector
AU6010294A (en) Modulators of gene expression
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7378396A (en) Transduction of hematopoietic cells by viral vector and a cationic lipid
AU5557196A (en) High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
AU5405496A (en) Manufacture of bags
AU5436196A (en) Fibrinogen-coated liposomes
AU3958895A (en) Membrane expression of heterologous genes
AU4185296A (en) Mobilisation of haematopoietic cells
AU3586595A (en) Preparation of immortalized cells
AU6746296A (en) Cell culture products
AU5033296A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
AU5989396A (en) Origin of replication complex genes
AU7716996A (en) A carburettor of the diaphragm type
AU5100596A (en) 3-aryluracils and intermediates for their preparation
AU7073994A (en) Packaging of enzymes
AU5226596A (en) A pair of spectacles